Abbott Laboratories (ABT): Price and Financial Metrics


Abbott Laboratories (ABT)

Today's Latest Price: $92.23 USD

0.59 (0.64%)

Updated Jul 2 7:00pm

Add ABT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ABT Stock Summary

  • Abbott Laboratories's market capitalization of $161,725,528,156 is ahead of 99.13% of US-listed equities.
  • Abbott Laboratories's stock had its IPO on January 1, 1986, making it an older stock than 92.91% of US equities in our set.
  • In terms of volatility of its share price, ABT is more volatile than only 1.7% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Abbott Laboratories are NVO, TMO, SAP, NKE, and ORCL.
  • ABT's SEC filings can be seen here. And to visit Abbott Laboratories's official web site, go to www.abbott.com.
ABT Daily Price Range
ABT 52-Week Price Range

ABT Stock Price Chart Technical Analysis Charts


ABT Price/Volume Stats

Current price $92.23 52-week high $100.00
Prev. close $91.64 52-week low $61.61
Day low $91.93 Volume 3,845,629
Day high $93.06 Avg. volume 8,351,287
50-day MA $91.23 Dividend yield 1.56%
200-day MA $85.79 Market Cap 163.14B

Abbott Laboratories (ABT) Company Bio


Abbott Laboratories manufactures and sells health care products worldwide. The company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The company was founded in 1888 and is based in Abbott Park, Illinois.

ABT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$92.23$39.96-55%

Below please find a table outlining a discounted cash flow forecast for ABT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Abbott Laboratories ranked in the 29th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Abbott Laboratories ended up being:

  • As a business, ABT is generating more cash flow than 91.53% of positive cash flow stocks in the Healthcare.
  • The business' balance sheet suggests that 10% of the company's capital is sourced from debt; this is greater than merely 21.87% of the free cash flow producing stocks we're observing.
  • ABT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 40.63% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-56%
1%-55%
2%-55%
3%-55%
4%-54%
5%-54%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ABT, try ESMC, HOLX, BHC, CNMD, and IONS.


ABT Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ABT Latest Social Stream


Loading social stream, please wait...

View Full ABT Social Stream

Latest ABT News From Around the Web

Below are the latest news stories about Abbott Laboratories that investors may wish to consider to help them evaluate ABT as an investment opportunity.

COVID-19: Significant Shift in Strategy of Global Automated Microbiology Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Agilent Technologies Inc. | Technavio

LONDON--(BUSINESS WIRE)-- #AutomatedMicrobiologyMarket20202024--The Global Automated Microbiology Market 2020-2024 will grow by $ 744.20 mn during 2020-2024

Business Wire | July 3, 2020

Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX

NEW YORK , July 2, 2020 /CNW/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(CODX) and certain of its officers. The class action, filed in United States District Court for the District of Utah , Central Division, and indexed under 20-cv-00481, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired Co-Diagnostics securities between February 25, 2020 , and May 15, 2020 , both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b -...

Yahoo | July 3, 2020

The Top-Ranked Dividend Growth Stocks In The Health Care Sector

The changing landscape in dividend growth investing is challenging. From an all-time high in late February, the S&P 500 lost more than 34% of its value due to uncertainties surrounding the impact of the coronavirus disease of 2019 (COVID-19) on the global economy. While the index has gained back most...

FerdiS on Seeking Alpha | July 2, 2020

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed the most recent trading day at $92.23, moving +0.64% from the previous trading session.

Yahoo | July 2, 2020

Abbott Laboratories (ABT): Were Hedge Funds Right About This Stock?

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. We are almost done with the second quarter. Investors decided […]

Yahoo | July 2, 2020

Read More 'ABT' Stories Here

ABT Price Returns

1-mo 4.51%
3-mo 16.57%
6-mo 7.73%
1-year 9.73%
3-year 98.56%
5-year 105.22%
YTD 7.08%
2019 22.08%
2018 29.06%
2017 52.03%
2016 -12.32%
2015 1.87%

ABT Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full ABT Dividend History

Continue Researching ABT

Here are a few links from around the web to help you further your research on Abbott Laboratories's stock as an investment opportunity:

Abbott Laboratories (ABT) Stock Price | Nasdaq
Abbott Laboratories (ABT) Stock Quote, History and News - Yahoo Finance
Abbott Laboratories (ABT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9024 seconds.